Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.2.2.22 extracted from

  • Adwan, H.; Bayer, H.; Pervaiz, A.; Sagini, M.; Berger, M.R.
    Riproximin is a recently discovered type II ribosome inactivating protein with potential for treating cancer (2014), Biotechnol. Adv., 32, 1077-1090.
    View publication on PubMed

Molecular Weight [Da]

Molecular Weight [Da] Molecular Weight Maximum [Da] Comment Organism
29000
-
1 * 29000 + 1 * 31000, SDS-PAGE Ximenia americana
31000
-
1 * 29000 + 1 * 31000, SDS-PAGE Ximenia americana

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
rRNA + H2O Ximenia americana
-
?
-
?

Organism

Organism UniProt Comment Textmining
Ximenia americana Q2PA54
-
-

Purification (Commentary)

Purification (Comment) Organism
Capto Q column chromatography and lactosyl–Sepharose column chromatography Ximenia americana

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
rRNA + H2O
-
Ximenia americana ?
-
?

Subunits

Subunits Comment Organism
heterodimer 1 * 29000 + 1 * 31000, SDS-PAGE Ximenia americana

Synonyms

Synonyms Comment Organism
riproximin
-
Ximenia americana
Rpx
-
Ximenia americana
type II ribosome inactivating protein
-
Ximenia americana